Decheng Capital Management Iii (Cayman), LLC Portfolio Holdings

Decheng Capital Management Iii (Cayman), LLC

  • $181 Million
  • Q3 2023

Decheng Capital Management Iii (Cayman), LLC has filed its 13F form on November 13, 2023 for Q3 2023 where it was disclosed a total value porftolio of $181 Million distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Zentalis Pharmaceuticals, Inc. with a value of $42.1M, Arcus Biosciences, Inc. with a value of $15.6M, 10x Genomics, Inc. with a value of $14.8M, Argenx Se with a value of $13.5M, and Pacific Biosciences Of California, Inc. with a value of $12.2M.

Examining the 13F form we can see an decrease of $7.97M in the current position value, from $189M to 181M.

Below you can find more details about Decheng Capital Management Iii (Cayman), LLC portfolio as well as his latest detailed transactions.

Portfolio value $181 Million
Healthcare: $181 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$171M
$42.1 Million 23.31% of portfolio
2,099,583
Q2 2023 Added 15.07%
$1.12B
$15.6 Million 8.64% of portfolio
869,790
Q3 2023 New
$1.33B
$14.8 Million 8.21% of portfolio
359,554
Q3 2022 Added 18.28%
$34.5B
$13.5 Million 7.46% of portfolio
27,429
Q1 2023 Added 396.09%
$443M
$12.2 Million 6.76% of portfolio
1,463,872
Q1 2022 New
$21.4B
$11.1 Million 6.14% of portfolio
80,859
Q4 2022 Reduced 37.87%
$240M
$10.4 Million 5.77% of portfolio
1,163,123
Q3 2023 Added 296.52%
$6.14B
$9.88 Million 5.47% of portfolio
142,196
Q3 2023 New
$0
$9.13 Million 5.05% of portfolio
78,900
Q3 2022 Added 42.42%
$292M
$8.81 Million 4.88% of portfolio
850,000
Q2 2023 New
$0
$6.6 Million 3.65% of portfolio
415,880
Q3 2023 New
$76.5M
$5.5 Million 3.04% of portfolio
4,166,667
Q3 2023 New
$0
$4.88 Million 2.7% of portfolio
23,014
Q3 2023 New
$0
$3.95 Million 2.19% of portfolio
8,980,909
Q1 2022 New
$220M
$3.59 Million 1.99% of portfolio
714,285
Q1 2022 New
$21M
$3.29 Million 1.82% of portfolio
4,447,308
Q1 2022 New
$32.7M
$1.27 Million 0.7% of portfolio
555,555
Q1 2022 New
$155M
$1.15 Million 0.64% of portfolio
904,268
Q1 2022 New
$36.4M
$274,000 0.15% of portfolio
200,201
Q3 2023 Reduced 60.41%
$129M
$35,000 0.02% of portfolio
103,604
Q2 2023 Reduced 96.97%
$49.3M
$0 0.0% of portfolio
-
Q3 2023 Reduced 82.75%
Roivant Sciences LTD
-
$0 0.0% of portfolio
-
Q2 2023 New
Acelyrin Inc(Nsm)
-
$0 0.0% of portfolio
-
Q3 2023 Reduced 0.39%
Alpine Immune Sciences, Inc.
-
$0 0.0% of portfolio
-
Q4 2022 New
Beyond Spring Inc.
-
$0 0.0% of portfolio
-
Q2 2023 New
Atri Cure Inc.
-
$0 0.0% of portfolio
-
Q2 2023 New

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $181 Million
  • Prior Value $189 Million
  • Filing
  • Period Q3 2023
  • Filing Date November 13, 2023
  • Form Type 13F-HR
  • Activity in Q3 2023
  • New Purchases 5 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Decheng Capital Management Iii (Cayman), LLC Portfolio

Follow Decheng Capital Management Iii (Cayman), LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital Management Iii (Cayman), LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital Management Iii (Cayman), LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email